Literature DB >> 21813667

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.

Yoon Seok Choi1, Yun Hee Baek, Wonseok Kang, Seung Joo Nam, Jino Lee, Sooseong You, Dong-Yeop Chang, Jong-Chan Youn, Young Ki Choi, Eui-Cheol Shin.   

Abstract

The vaccination program against the 2009 pandemic H1N1 influenza virus (2009 H1N1) provided a unique opportunity to determine if immune responses to the 2009 H1N1 vaccine were affected by a recent, prior vaccination against seasonal influenza virus. In the present study, we studied the immune responses to the 2009 H1N1 vaccine in subjects who either received the seasonal influenza virus vaccination within the prior 3 months or did not. Following 2009 H1N1 vaccination, subjects previously given a seasonal influenza virus vaccination exhibited significantly lower antibody responses, as determined by hemagglutination inhibition assay, than subjects who had not received the seasonal influenza virus vaccination. This result is compatible with the phenomenon of "original antigenic sin," by which previous influenza virus vaccination hampers induction of immunity against a new variant. Our finding should be taken into account for future vaccination programs against pandemic influenza virus outbreaks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813667      PMCID: PMC3165229          DOI: 10.1128/CVI.05053-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  19 in total

1.  New influenza A (H1N1) virus: global epidemiological situation, June 2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-06-19

2.  Response to a monovalent 2009 influenza A (H1N1) vaccine.

Authors:  Michael E Greenberg; Michael H Lai; Gunter F Hartel; Christine H Wichems; Charmaine Gittleson; Jillian Bennet; Gail Dawson; Wilson Hu; Connie Leggio; Diane Washington; Russell L Basser
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

3.  A novel influenza A (H1N1) vaccine in various age groups.

Authors:  Feng-Cai Zhu; Hua Wang; Han-Hua Fang; Jian Guo Yang; Xiao Jun Lin; Xiao-Feng Liang; Xue-Feng Zhang; Hong-Xing Pan; Fan-Yue Meng; Yue Mei Hu; Wen-Dong Liu; Chang-Gui Li; Wei Li; Xiang Zhang; Jin Mei Hu; Wei Bing Peng; Bao Ping Yang; Pei Xi; Hua-Qing Wang; Jing-Shan Zheng
Journal:  N Engl J Med       Date:  2009-10-21       Impact factor: 91.245

4.  Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Authors:  Terry Nolan; Jodie McVernon; Maryanne Skeljo; Peter Richmond; Ushma Wadia; Stephen Lambert; Michael Nissen; Helen Marshall; Robert Booy; Leon Heron; Gunter Hartel; Michael Lai; Russell Basser; Charmaine Gittleson; Michael Greenberg
Journal:  JAMA       Date:  2009-12-21       Impact factor: 56.272

5.  Seasonal influenza vaccine provides priming for A/H1N1 immunization.

Authors:  Giuseppe Del Giudice; Koert J Stittelaar; Geert van Amerongen; James Simon; Albert D M E Osterhaus; Klaus Stöhr; Rino Rappuoli
Journal:  Sci Transl Med       Date:  2009-12-23       Impact factor: 17.956

6.  Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Authors:  Eric Plennevaux; Eric Sheldon; Mark Blatter; Mary-Kate Reeves-Hoché; Martine Denis
Journal:  Lancet       Date:  2009-12-15       Impact factor: 79.321

7.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

8.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Authors:  Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

9.  Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Authors:  Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

10.  Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection.

Authors:  Philippe Noriel Q Pascua; Min-Suk Song; Jun Han Lee; Kuk Jin Park; Hyeok-Il Kwon; Yun Hee Baek; Seung-Pyo Hong; Jong-Bok Rho; Chul-Joong Kim; Haryoung Poo; Thomas S Ryoo; Moon-Hee Sung; Young Ki Choi
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more
  23 in total

Review 1.  Influenza vaccine failure: failure to protect or failure to understand?

Authors:  Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-06-26       Impact factor: 5.217

2.  Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

Authors:  Thomas F Rogers; Eileen C Goodwin; Bryan Briney; Devin Sok; Nathan Beutler; Alexander Strubel; Rebecca Nedellec; Khoa Le; Michael E Brown; Dennis R Burton; Laura M Walker
Journal:  Sci Immunol       Date:  2017-08-18

3.  Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination.

Authors:  Rodrigo B Abreu; Greg A Kirchenbaum; Emily F Clutter; Giuseppe A Sautto; Ted M Ross
Journal:  JCI Insight       Date:  2020-01-16

4.  Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance.

Authors:  Martina Kosikova; Lei Li; Peter Radvak; Zhiping Ye; Xiu-Feng Wan; Hang Xie
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

5.  Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors.

Authors:  Tessie B McNeely; Najaf A Shah; Arthur Fridman; Amita Joshi; Jonathan S Hartzel; Ravi S Keshari; Florea Lupu; Mark J DiNubile
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.

Authors:  Lalita Priyamvada; Alice Cho; Nattawat Onlamoon; Nai-Ying Zheng; Min Huang; Yevgeniy Kovalenkov; Kulkanya Chokephaibulkit; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Rafi Ahmed; Patrick C Wilson; Jens Wrammert
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus.

Authors:  Christopher D O'Donnell; Amber Wright; Leatrice Vogel; Kobporn Boonnak; John J Treanor; Kanta Subbarao
Journal:  Clin Vaccine Immunol       Date:  2014-03-19

Review 8.  Novel viral vectored vaccines for the prevention of influenza.

Authors:  Teresa Lambe
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

9.  Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Naveed Z Janjua; Gaston De Serres; Jennifer L Gardy; Chantal Rhéaume; Xavier Bouhy; Guy Boivin
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

10.  Comparison of immune response by virus infection and vaccination to 2009 pandemic influenza A/H1N1 in children.

Authors:  Eun Kyeong Kang; Jung Sub Lim; Jun Ah Lee; Dong Ho Kim
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.